Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tag: SOP for Protein Binding Studies

SOP for Ensuring Data Quality in Preclinical Studies

Posted on By

SOP for Ensuring Data Quality in Preclinical Studies Standard Operating Procedure (SOP) for Ensuring Data Quality in Preclinical Studies 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for ensuring the quality of data generated during preclinical studies. Data quality is crucial for making informed decisions during drug development, ensuring…

Read More “SOP for Ensuring Data Quality in Preclinical Studies” »

Drug Discovery

SOP for Analysis of Protein Binding in Drug Development

Posted on By

SOP for Analysis of Protein Binding in Drug Development Standard Operating Procedure (SOP) for Analysis of Protein Binding in Drug Development 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to define the procedures for analyzing protein binding in drug development. Protein binding is a critical pharmacokinetic property that influences the distribution, metabolism,…

Read More “SOP for Analysis of Protein Binding in Drug Development” »

Drug Discovery

SOP for Phototoxicity Testing in Preclinical Studies

Posted on By

SOP for Phototoxicity Testing in Preclinical Studies Standard Operating Procedure (SOP) for Phototoxicity Testing in Preclinical Studies 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to define the procedures for conducting phototoxicity testing in preclinical studies. Phototoxicity testing is essential for assessing the potential of a drug or chemical compound to cause…

Read More “SOP for Phototoxicity Testing in Preclinical Studies” »

Drug Discovery

SOP for Preparing Preclinical Dossiers for Regulatory Submissions

Posted on By

SOP for Preparing Preclinical Dossiers for Regulatory Submissions Standard Operating Procedure (SOP) for Preparing Preclinical Dossiers for Regulatory Submissions 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to define the procedures for preparing preclinical dossiers required for regulatory submissions. These dossiers include essential data from preclinical studies that demonstrate the safety, pharmacokinetics,…

Read More “SOP for Preparing Preclinical Dossiers for Regulatory Submissions” »

Drug Discovery

SOP for Conducting Biodistribution Studies

Posted on By

SOP for Conducting Biodistribution Studies Standard Operating Procedure (SOP) for Conducting Biodistribution Studies 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the procedures for conducting biodistribution studies. These studies are crucial for assessing the distribution, localization, and concentration of a drug or its metabolites within various tissues and organs after…

Read More “SOP for Conducting Biodistribution Studies” »

Drug Discovery

SOP for Translational Studies Linking Preclinical and Clinical Phases

Posted on By

SOP for Translational Studies Linking Preclinical and Clinical Phases Standard Operating Procedure (SOP) for Translational Studies Linking Preclinical and Clinical Phases 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the procedures for conducting translational studies that bridge preclinical and clinical phases of drug development. Translational studies aim to apply preclinical…

Read More “SOP for Translational Studies Linking Preclinical and Clinical Phases” »

Drug Discovery

SOP for PK/PD Modeling in Preclinical Studies

Posted on By

SOP for PK/PD Modeling in Preclinical Studies Standard Operating Procedure (SOP) for PK/PD Modeling in Preclinical Studies 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to define the procedures for performing pharmacokinetic (PK) and pharmacodynamic (PD) modeling in preclinical studies. PK/PD modeling is essential for understanding the relationship between the drug concentration…

Read More “SOP for PK/PD Modeling in Preclinical Studies” »

Drug Discovery

SOP for Conducting Exploratory Toxicology Studies

Posted on By

SOP for Conducting Exploratory Toxicology Studies Standard Operating Procedure (SOP) for Conducting Exploratory Toxicology Studies 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to define the procedures for conducting exploratory toxicology studies. These studies aim to evaluate the potential toxic effects of a drug candidate in an early stage of development. Exploratory…

Read More “SOP for Conducting Exploratory Toxicology Studies” »

Drug Discovery

SOP for Preclinical Safety Pharmacology Studies

Posted on By

SOP for Preclinical Safety Pharmacology Studies Standard Operating Procedure (SOP) for Preclinical Safety Pharmacology Studies 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the procedures for conducting preclinical safety pharmacology studies. These studies are essential for evaluating the potential effects of a drug candidate on vital organ systems, including the…

Read More “SOP for Preclinical Safety Pharmacology Studies” »

Drug Discovery

SOP for Integration of Preclinical Data into IND Submission

Posted on By

SOP for Integration of Preclinical Data into IND Submission Standard Operating Procedure (SOP) for Integration of Preclinical Data into IND Submission 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to define the procedures for integrating preclinical study data into an Investigational New Drug (IND) submission. This SOP ensures that preclinical data is…

Read More “SOP for Integration of Preclinical Data into IND Submission” »

Drug Discovery

Posts pagination

Previous 1 … 6 7 8 … 16 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme